Clavel et al., 2014 - Google Patents
Discovery of a highly tumor-selective organometallic ruthenium (II)–arene complexClavel et al., 2014
- Document ID
- 405706722706454381
- Author
- Clavel C
- Paunescu E
- Nowak-Sliwinska P
- Griffioen A
- Scopelliti R
- Dyson P
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
A ruthenium (II)–arene complex with a perfluoroalkyl-ligand was found to display remarkable selectivity toward cancer cells. IC50 values on several cancer cell lines are in the range of 25–45 μM, and no cytotoxic effect was observed on nontumorigenic (HEK-293) cells at …
- 229910052707 ruthenium 0 title abstract description 69
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0086—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Clavel et al. | Discovery of a highly tumor-selective organometallic ruthenium (II)–arene complex | |
| Clavel et al. | Modulating the anticancer activity of ruthenium (II)–arene complexes | |
| Hearn et al. | Organometallic iridium (III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis | |
| Castonguay et al. | New ruthenium (II)–letrozole complexes as anticancer therapeutics | |
| Yellol et al. | Novel C, N-cyclometalated benzimidazole ruthenium (II) and iridium (III) complexes as antitumor and antiangiogenic agents: a structure–activity relationship study | |
| Nowak-Sliwinska et al. | Organometallic ruthenium (II) arene compounds with antiangiogenic activity | |
| Suntharalingam et al. | A breast cancer stem cell-selective, mammospheres-potent osmium (VI) nitrido complex | |
| Pettinari et al. | Ruthenium (II)–arene RAPTA type complexes containing curcumin and bisdemethoxycurcumin display potent and selective anticancer activity | |
| Hudej et al. | Synthesis and biological evaluation of the thionated antibacterial agent nalidixic acid and its organoruthenium (II) complex | |
| Kumar et al. | Potent anticancer activity with high selectivity of a chiral palladium N-Heterocyclic Carbene Complex | |
| Pérez et al. | New acridine thiourea gold (I) anticancer agents: Targeting the nucleus and inhibiting vasculogenic mimicry | |
| Mendes et al. | Metal-based inhibition of poly (ADP-ribose) polymerase− The guardian angel of DNA | |
| Seršen et al. | Structure-related mode-of-action differences of anticancer organoruthenium complexes with β-diketonates | |
| Kurzwernhart et al. | Structure–activity relationships of targeted RuII (η6-p-Cymene) anticancer complexes with flavonol-derived ligands | |
| Cunha et al. | Selective coordination mode of acylthiourea ligands in half-sandwich Ru (II) complexes and their cytotoxic evaluation | |
| Martínez et al. | Searching for new chemotherapies for tropical diseases: Ruthenium–clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells | |
| Aman et al. | Anticancer ruthenium (η6-p-cymene) complexes of nonsteroidal anti-inflammatory drug derivatives | |
| Ruiz et al. | Novel bis-C, N-cyclometalated iridium (III) thiosemicarbazide antitumor complexes: Interactions with human serum albumin and DNA, and inhibition of cathepsin B | |
| Agonigi et al. | Synthesis and antiproliferative activity of new ruthenium complexes with ethacrynic-acid-modified pyridine and triphenylphosphine ligands | |
| Chtchigrovsky et al. | Antitumor trans-N-heterocyclic carbene–amine–Pt (II) complexes: synthesis of dinuclear species and exploratory investigations of DNA binding and cytotoxicity mechanisms | |
| Zamora et al. | Dual antitumor and antiangiogenic activity of organoplatinum (II) complexes | |
| Nazarov et al. | Anthracene-tethered ruthenium (II) arene complexes as tools to visualize the cellular localization of putative organometallic anticancer compounds | |
| Zhao et al. | Anticancer activity of bifunctional organometallic Ru (II) arene complexes containing a 7-hydroxycoumarin group | |
| Panchangam et al. | Antitumor effects of Ir (III)-2 H-indazole complexes for triple negative breast cancer | |
| Maji et al. | Effect of an imidazole-containing schiff base of an aromatic sulfonamide on the cytotoxic efficacy of N, N-coordinated half-sandwich ruthenium (II) p-cymene complexes |